Clinical Trial Update: A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors [NA]

View source ↗

Summary

This clinical trials entry describes a multicenter, open-label randomized study evaluating Romiplostim N01 for chemotherapy- or chemoradiotherapy-induced thromb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia
• Solid Malignant Neoplasms
• Thrombocytopenia

Drugs mentioned

• Romiplostim N01 (romiplostim)

Snippet

Sponsor: Jun wang | Conditions: Solid Tumor Malignancies, Cancer, CTIT-Chemotherapy Induced Thrombocytopenia | NA | Status: NOT_YET_RECRUITING